We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Separator Tubes Assessed for Measurement of 25-Hydroxyvitamin D3

By LabMedica International staff writers
Posted on 17 Feb 2016
The accuracy of 25-hydroxyvitamin D3 (25OHD3) measurement on specimens collected into serum separator tubes (SSTs) has been questioned because of possible interference by the gel.

High performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are still considered the reference methods for vitamin D measurement although commercial immunoassays have been developed to satisfy increased demand for 25OHD measurement.

A team of scientists including those from the Royal Surrey County Hospital and their colleagues in Saudi Arabia collected blood specimens were from 50 healthy volunteers (22 males, 28 females, aged 42.6 ± 11.2 and BMI 27.4 ± 5.2 kg/m2), ten of whom were taking 25OHD3 supplements. Blood specimens were simultaneously collected into plain vacutainer tubes and serum-separating advance vacutainer tubes (SST II) using a standard venesection procedure. Specimens were centrifuged within one hour of blood collection and the serum transferred into secondary tubes. Serum was stored at -80 °C until analysis six months later.

All vacutainers used were from Becton Dickinson (BD; Franklin Lakes, NJ, USA) and 25OHD3 was assayed on serum using high performance liquid chromatography (Waters Corporation; Milford, MA, USA), and immunoassays from Architect (Abbott Diagnostics; Abbott Park, IL, USA) and Liaison (DiaSorin; Saluggia, Italy).

The authors found there were no significant differences between 25OHD3 results (means ± SE, nmol/l) obtained from specimens collected into plain tubes and SSTs assayed by HPLC (39.0 ± 2.7 vs. 39.3 ± 2.7), Liaison (32.9 ± 2.2 vs. 32.8 ± 2.3), or Architect (43.1 ± 2.8 vs. 43.2 ± 2.8). In specimens collected into plain tubes and SSTs, 25OHD3 measurements by HPLC correlated significantly with those from the Architect and Liaison respectively.

The authors concluded that the gel in BD’s SSTs does not interfere with the measurement of 25OHD3 by HPLC or by the commercial immunoassays tested. This important finding may enable clinical laboratories to make cost savings by using SSTs without concerns about inaccuracy. The study was published in the January 2016 issue of the Journal of Clinical Laboratory Analysis.

Related Links:

Royal Surrey County Hospital
Becton Dickinson 
Waters Corporation 



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.